UCB Group

Headquarters location: Allée de la Recherche 60 1070 Brussels Tel. 32-2-559-99-99 Job offers, investor relations: www.ucb-group.com Stock:

UCB Group owns subsidiary country     % source Genfit Les Echos Schwarz Pharma AG 100 Bloomberg	Brands name items photo compare the prices Actias Réassurance SA Ethishop Celltech Group Ethishop Cogefina SA Ethishop Crylcoat Ethishop Doutors Reassurance SA Ethishop Fipar Ltd Ethishop Lortab Ethishop Société Financière UCB SA Ethishop Surface Specialities Italy Srl Ethishop UCB Ethishop UNI Mediflex Private Ethishop Union Chimique Belge Ethishop Vedim Ethishop Zyrtec Ethishop Shop local, ethical and at the best price on Ethishop !
« ETHICAL » RATING OF UCB_GROUP , group and subsidiaries [?] 3% Job: 3% of company's jobs cut since 1998 1 Environment: 1 major pollution(s) 1 Delinquency: 1 act(s) of financial or trade delinquency 6 Tax haven, secret bank account, shell companies: operates in 6 offshore financial center(s) 2 Net profit: more than 2 billion(s) dollars/euros in cumulated net profit since 1998 4 Influence: 4 act(s) of direct corruption or lobbying 1 Advertising & marketing: 1 dubious practice(s) Full profile >>>
World locations & Manufacturing country incentive : address & contact : production type source   UCB Ltd. :   UCB do Brasil Lda. :   Shangai UCB Speciality Chemicals Co. Ltd. :   SK UCB Co. Ltd. (50%) :   Korea UCB Co. Ltd. : UCB Pharma Ltd. :   UCB Hungary :   UNI Mediflex Private Ltd. :   UCB India Private Ltd. : UCB Ireland Ltd : Société Financière UCB SA : Actias Réassurance SA :   UCB Asia Pacific Sdn Bhd :   UCB de Mexico SA de CV :   Vedim SA de CV : UCB Philippines Inc. :   Vedim Sp. z o.o. :   UCB Pharma Sp. z o.o. :   UCB Pharma SRO : UCB Singapore Private Ltd. : UCB Investissements SA : Doutors Reassurance SA : Cogefina SA : UCB Pharma AG : UCB Farchim SA :   Fipar Ltd :   Surface Specialities Ltd. (96,27%) :   UCB Pharma Ltd. :   UCB Pharma AS : The map of tax haven, secret accounts and shell companies UCB Group is managed by year name photo position; compensation source 2004Janssen, André Honorary Director; 2003Belgium, H.R.H. Prince Lorenz of Director; 2003Blinken, Alain Director; 2003Boone, Baron Karel Director; 2003DIDISHEIM, Count Honorary Director; 2003Janssen, Baron Daniel Deputy Chairman; 2003Jaumotte, Baron Honorary Chairman of the Board of Directors; 2003KEUTGEN, Guy Director; 2003Roden, Baron de Neve de Honorary Director; 2003Van Rijckevorsel, Jean Director; 2003VELGE, Baron Honorary Director; 2000DIDISHEIM, Count Director; 2000Du Monceau de Bergendal, Count Diego Director; 2000EYSKENS, Mark Chairman of the Board; 2000JACOBS, Baron Director; 2000Janssen, Baron Daniel Director; 2000JANSSEN, Eric Director; 2000KEUTGEN, Guy Director; 2000SAVERYS, Philippe Director; 2000VANHERWEGHEM, Jean-Louis Director; 2000VELGE, Baron Director; Highest paid executives in 2007 Advertising & marketing year dubious practice : image source 2003 Arguable partnership: Red Cross through the latter's annual campaign of self-adhesive stickers.: Dubious practices in 2007

Made by year employees <> social impact : country source 2007 -219 Merger/Acquisition: UCB cuts 40% of its payroll in France because of its merger with Schwarz and the price falls of its drugs decided by the government.: France Les Echos 2004 -80 2003 11559 2002 10326 2000 9910 1999 8000 Layoff plans and labour conditions in 2007 Environmental impact year country : consequences source 2004 France : Condamné par la justice française à verser 310.000 euros de dommages et intérêts à deux jeunes femmes atteintes d'un cancer causé par la prise de Distilbène (DES) par leur mère lors de sa grossesse. Décision confirmée par la Cour de cassation: "Devant ces risques connus et identifiés sur le plan scientifique, UCB Pharma n'avait pris aucune mesure, ce qu'elle aurait dû faire même en présence de résultats discordants quant aux avantages et inconvénients", a jugé la Cour. Les Echos Pollutions in 2007 Influence year purpose : intermediary/lobby : institution source 2000 Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translate EFPIA 1999 Market admission for genetically modified organisms : EuropaBio : : European Commission translate Corporate . Influence in 2007 Financials year financial misdemeanor sales income source 2004   3.07 0.36   billion Eu€ 2004 Amende de 10 millions d'euros infligée par la Commission Européenne pour cartel de la vitamine B-4     Reuters 2003   2.96 0.34   billion Eu€ Les Echos 2002   2.51 0.33   billion Eu€ 2001   2.48 0.32   billion Eu€ 2000   2.44 0.25   billion US$ Financial delinquency in 2007

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >

---

---

---

Further investigation

Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.

Name (or ninckname)*		Email
Title*		Link to document online
Information*
Alert me of answers by email			* required field
Please copy the antispam code:

The 5 latest validated comments

Target   Target writes off 8.1% of its annualized credit card debt in March - Friday 2 May 2008 at 11h07

Dell computer   Dell confirms plan to cut 250 Irish jobs - Friday 2 May 2008 at 08h50

Henry   leatest profile of hery sy - Tuesday 29 April 2008 at 07h08

Dow jones   Wall Street Journal managing editor stepping down - Tuesday 22 April 2008 at 08h09

Lehman brothers   Lehman liquidates three funds - Thursday 17 April 2008 at 14h46

All comments